| Tetsuro Ago | Last modified date：2023.11.22 |
Associate Professor /
Department of Medicine and Clinical Science, Graduate School of Medical Sciences /
Department of Clinical Medicine /
Faculty of Medical Sciences
Reports
| 1. | Kiyohara T, Ago T, Can calcium channel blockers prevent ischemic stroke in nonvalvular atrial fibrillation patients?—the optimal choice of antihypertensive drug for subtype-specific stroke prevention., Hypertens Res, 2022.03. |
| 2. | Yao H, Ago T, Kitazono T, Nabika T, NADPH Oxidase-Related Pathophysiology in Experimental Models of Stroke, Int J Mol Sci, 2017.10. |
| 3. | Kamouchi M, Ago T, Kuroda J, Kitazono T. , The possible roles of brain pericytes in brain ischemia and stroke, Cell Mol Neurobiol, 2012.03. |
| 4. | Ago T, Kuroda J, Kamouchi M, Sadoshima J, Kitazono T. , Pathophysiological Roles of NADPH Oxidase/Nox Family Proteins in the Vascular System – Review and Perspective – , Circulation Journal , 2011.07, [URL]. |
| 5. | Kamouchi M, Ago T, Kitazono T., Brain pericytes: emerging concepts and functional roles in brain homeostasis., Cell Mol Neurobiol. , 2011.03. |
| 6. | Ago T, Matsushima S, Kuroda J, Zablocki D, Kitazono T, Sadoshima J., The NADPH oxidase Nox4 and aging in the heart, Aging, 2010.12. |
| 7. | Oka S, Ago T, Kitazono T, Zablocki D, Sadoshima J. , The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy. , J Mol Med , 2009.08. |
| 8. | Ago T, Worsening of Ipsilateral Hemiparesis After Recurrent Stroke. , Journal Watch Neurology , 2007.09. |
| 9. | Ago T, Sadoshima J. , Thioredoxin1 as a negative regulator of cardiac hypertrophy. , 2007.06. |
| 10. | Ago T, Sadoshima J. , Thioredoxin and ventricular remodeling., J Mol Cell Cardiol , 2006.11. |
| 11. | Ago T, Sadoshima J. , GDF15, a cardioprotective TGF-beta superfamily protein. , Circ Res , 2006.02. |
Unauthorized reprint of the contents of this database is prohibited.